Philadelphia CEO Named to Small Business Association Leadership Council

PHILADELPHIA, May 15, 2017 – Trovita Health Science CEO Will Brown was recently named to the National Small Business Association (NSBA) Leadership Council. NSBA is the nation’s oldest small-business advocacy organization, and operates on a staunchly nonpartisan basis. Brown, a recognized leader in the Philadelphia business community, joins the NSBA Leadership Council alongside other small-business advocates from across the country as they work to promote the interests of small business to policymakers in Washington, D.C.


Trovita Health Science Announces FDA Marketing Clearance of New SAFE-T FEED™ Nutrition Delivery Device for Tube Feeding

PHILADELPHIA, March 20, 2017 –Trovita Health Science, an emerging life science company specializing in medical nutrition, announces U.S. Food and Drug Administration marketing authorization of the new SAFE-T FEED™ device for administering tube feeding formulas. The nutrition delivery device is a novel, ready-to-feed pouch offering the first and only fully-closed system, pre-packaged with complete enteral formulas.


Trovita Announces FDA 510(k) Submission of New, Fully Closed Tube Feeding System

PHILADELPHIA, December 20, 2016 –Trovita Health Science, an emerging life science company specializing in clinical nutrition innovation, announces the 510(k) submission for clearance of a new tube feeding system offering the first and only method for administering bolus or gravity tube feeding in a fully closed system, without the need for pouring formulas through a syringe, or utilizing an electronic pump system.


Dr. Harold Smith Appointed Senior Advisor to Trovita Health Science

Molecular Biologist and Professor at University of Rochester School of Medicine and Dentistry Joins Trovita’s Scientific Advisory Board

Minneapolis, M.N., February 22, 2016Trovita Health Science, an emerging life science company focused in clinical nutrition innovation appointed Dr. Harold Smith, molecular biologist and Professor at University of Rochester School of Medicine and Dentistry, as a senior advisor on Trovita’s Scientific Advisory Board. Additionally, Dr. Smith is CEO of OyaGen, Inc., a Rochester, New York based pre-clinical biotechnology company focused on developing new mechanisms of action to treat and cure a spectrum of diseases, including a platform for HIV/AIDS, ebola virus, and oncology.


ENU® Featured in Leading National Publication, HIVPlus – Called “Far Superior” Nutrition

Minneapolis, M.N., February 17, 2016ENU® complete nutrition shakes, Trovita Health Science’s flagship line of enteral nutrition formulas, is featured in the March-April issue of HIVPlus Magazine. The article addresses on-going concerns of unintended weight loss, and protein and micronutrient deficiencies in HIV patients, and recommends ENU as an optimal choice for nutrition support for this patient demographic to maintain weight, without excessive sugar consumption.


Hospitals, Distributors Overlook New FDA Sugar Recommendations

Minneapolis, M.N., January 11, 2016 – In November 2015, the U.S. Food and Drug
Administration recommended that people consume no more than 50 grams of sugar
per day.  This marked the first time the FDA adopted a position on sugar intake, and
many experts acknowledge the guidance is long overdue given the growing number
of health issues linked to high sugar consumption.

A category of medical nutrition that is consistently overlooked in the discussion
about reducing sugar consumption are nutritional shakes…